These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1233214)

  • 1. Excretion of norephedrine by man after oral administration of oxyfedrine.
    Appel E; Planz G; Palm D; Grobecker H; Stratmann D; Donike M
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):161-6. PubMed ID: 1233214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline depleting effect and metabolism of oxyfedrine in rats.
    Appel E; Planz G; Schmid B; Palm D; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 280(4):373-90. PubMed ID: 4274704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stability of oxyfedrine in pharmacological experiments in vitro].
    Brandt W
    Arzneimittelforschung; 1975 Jun; 25(6):856-9. PubMed ID: 1174320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Syntheses of 14C-1-erythro-norephedrine and its N-substitution products 14C-oxyfedrine and 14C-D 13,625].
    Bickel E; Engel J; Klingler KH
    Arzneimittelforschung; 1983; 33(9):1213-5. PubMed ID: 6685500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of DL-oxyfedrine HCl after single-dose oral administration of tablets as compared to equimolar solutions.
    Wetzelsberger N; Birkel M; Fuder H; Lücker PW; Stiegler S; Scheithauer S; Thümmler D
    Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):185-91. PubMed ID: 8531509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of oxyfedrine.
    Sakai K; Sugano S; Watanabe I; Fukushima M; Takanashi S; Nishii Y
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(3):323-37. PubMed ID: 4265889
    [No Abstract]   [Full Text] [Related]  

  • 7. Species differences in the metabolism of norephedrine in man, rabbit and rat.
    Sinsheimer JE; Dring LG; Williams RT
    Biochem J; 1973 Nov; 136(3):763-71. PubMed ID: 4780698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bio-availability of beta-acetyldigoxine (Novodigal) alone and combined with oxyfedrine (Ildamen-Novodigal).
    Bonelli J; Hruby K; Magometschnigg D; Hitzenberger G; Kaik G
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):288-93. PubMed ID: 881282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and elimination profile of cathinone in equine after norephedrine (Propalin®) administration using a validated liquid chromatography-tandem mass spectrometry method.
    Yi R; Zhao S; Lam G; Sandhu J; Loganathan D; Morrissey B
    Anal Bioanal Chem; 2013 Dec; 405(30):9711-22. PubMed ID: 23954941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of cathinone to (-)-norephedrine and (-)-norpseudoephedrine.
    Brenneisen R; Geisshüsler S; Schorno X
    J Pharm Pharmacol; 1986 Apr; 38(4):298-300. PubMed ID: 2872296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.
    Parratt JR
    Br J Pharmacol; 1974 May; 51(1):5-13. PubMed ID: 4155336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of ( 14 C)methamphetamine in man, the guinea pig and the rat.
    Caldwell J; Dring LG; Williams RT
    Biochem J; 1972 Aug; 129(1):11-22. PubMed ID: 4646771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.
    Csajka C; Haller CA; Benowitz NL; Verotta D
    Br J Clin Pharmacol; 2005 Mar; 59(3):335-45. PubMed ID: 15752380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of (-)-, (+)- and (+/-)-norephedrine. Plasma concentrations, serum protein binding and urinary excretions].
    Kamakura H; Satake M
    Yakugaku Zasshi; 1998 Apr; 118(4):143-9. PubMed ID: 9564791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic fate of 2H-labelled propafenone in man.
    Hege HG; Hollmann M; Kaumeier S; Lietz H
    Eur J Drug Metab Pharmacokinet; 1984; 9(1):41-55. PubMed ID: 6714269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of (S)-(-)-cathinone and its metabolites (R,S)-(-)-norephedrine and (R,R)-(-)-norpseudoephedrine in urine by high-performance liquid chromatography with photodiode-array detection.
    Mathys K; Brenneisen R
    J Chromatogr; 1992 Feb; 593(1-2):79-85. PubMed ID: 1639915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of DL-norephedrine 14C in the rat].
    Thiercelin JF; Jacquot C; Rapin JR; Cohen Y
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):153-63. PubMed ID: 782391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of amphetamine and norephedrine in the Tamarin monkey compared with man.
    Dring LG; Franklin RB; Williams RT
    West Afr J Pharmacol Drug Res; 1975 Jun; 2(1):26-30. PubMed ID: 1226730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of action of oxyfedrine as a partial beta receptor agonist].
    Sternitzke N; Schieffer H; Rettig G; Bette L
    Z Kardiol; 1984 Sep; 73(9):586-93. PubMed ID: 6095552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxyfedrine in coronary therapy].
    Wallner H; Sternitzke N; Schieffer H
    ZFA (Stuttgart); 1980 Mar; 56(9 Suppl):612-6. PubMed ID: 7234092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.